Lakewood-Amedex Biotherapeutics SEC Filing Effectiveness

Ticker: LABT · Form: EFFECT · Filed: Apr 20, 2026 · CIK: 0002079272

Sentiment: neutral

Topics: registration-statement, effectiveness, sec-filing

TL;DR

Lakewood-Amedex (CIK 0002079272) SEC filing EFFECT accepted 4/20/26. Registration statement is now effective.

AI Summary

Lakewood-Amedex Biotherapeutics Inc. filed an EFFECT form with the SEC on April 20, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001238, relates to Act 33 and File No. 333-292664. The company's mailing and business address is 8031 Cooper Creek Blvd., Suite 103, University Park, FL 34201.

Why It Matters

This filing signifies that a registration statement for Lakewood-Amedex Biotherapeutics Inc. has become effective, potentially paving the way for new securities offerings or other regulatory actions.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming the effectiveness of a registration statement, not indicating immediate financial risk or opportunity.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of an EFFECT filing?

An EFFECT filing signifies that a registration statement filed with the SEC has become effective, meaning the securities described in the registration statement can now be sold.

When was the Lakewood-Amedex Biotherapeutics Inc. filing accepted by the SEC?

The filing was accepted on April 20, 2026.

What is the effectiveness date mentioned in the filing?

The effectiveness date is April 17, 2026.

What is the CIK number for Lakewood-Amedex Biotherapeutics Inc.?

The CIK number for Lakewood-Amedex Biotherapeutics Inc. is 0002079272.

Where is Lakewood-Amedex Biotherapeutics Inc. located?

The company's mailing and business address is 8031 Cooper Creek Blvd., Suite 103, University Park, FL 34201.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 20, 2026 regarding Lakewood-Amedex Biotherapeutics Inc. (LABT).

View full filing on EDGAR

View Full Filing

View this EFFECT filing on SEC EDGAR

View on Read The Filing